2 = cueston o ‘or LS 4 Mark mone i snc ® alll. a cot so Gs) &.
3
: A 45-year-old woman is hospitalized due to severe Pneumocystis pneumonia. The patient has
6 a history of injection drug use and was diagnosed with HIV 10 years ago. She does not
z adhere to antiretroviral therapy and has developed resistance to multiple antiretroviral
9 medications. Laboratory evaluation reveals severe immunosuppression with a high HIV viral
s load. After the patient is adequately treated for pneumonia, HIV genotypic analysis is
12 performed. The viral isolates are found to have a mutation in the variable (V3) region of the

env gene, which makes the virus capable of infecting T cells with a specific surface receptor,

+ 15 but infection of macrophages is inefficient. Which of the following antiretroviral medications is

most likely to be ineffective in this patient?

(©) A. Atazanavir
©) B. Efavirenz

©) C. Enfuvirtide
©) D. Maraviroc

©) E. Raltegravir

©) F. Tenofovir Activate Windows

End Block

Waiting for www.uworl

